Loading people...
Dave Wigder is the Director of Product at PathAI, a leading company in AI-powered pathology. He is also an active investor, specializing in early-stage companies within healthcare AI, digital health, and B2B SaaS for the life sciences sector.
Dave Wigder invests in early-stage companies focused on healthcare artificial intelligence, digital health solutions, B2B SaaS platforms for life sciences, diagnostics, personalized medicine, and technologies that optimize clinical workflows and data analytics in healthcare.
Dave Wigder works as the Director of Product at PathAI, a company dedicated to applying AI to pathology for improved diagnostics and drug development.
Dave Wigder is a business professional operating within the technology and startup ecosystems, though his current executive role and primary geographic location remain publicly undisclosed. He completed his undergraduate education at Monmouth University, where he earned a Bachelor of Science degree in Business Management. This academic foundation provided him with formal training in organizational leadership, strategic planning, and corporate operations, which are typically utilized to scale early-stage ventures and manage complex business initiatives. While specific details regarding his historical career trajectory, past corporate affiliations, and precise operational metrics are not widely documented in standard public financial databases, his professional background is broadly aligned with the commercial technology sector. Ultimately, Wigder represents a management-trained professional whose current operational focus and specific industry contributions remain private within the broader venture capital and startup landscape.
Dave Wigder is a distinguished figure in the intersection of product leadership, artificial intelligence, and healthcare technology, currently holding the position of Director of Product at PathAI. PathAI is at the forefront of applying AI to pathology, transforming diagnostic capabilities and accelerating drug development. In his role, Dave is instrumental in guiding the strategic direction and development of cutting-edge products that leverage machine learning to improve patient outcomes and streamline medical research.
Beyond his significant contributions at PathAI, Dave Wigder is also an active investor, channeling his insights and capital into promising early-stage ventures. His investment thesis is deeply informed by his professional experience, focusing primarily on companies that are innovating within healthcare AI, digital health, and B2B SaaS solutions for the life sciences and medical industries. He seeks out opportunities where technology can create scalable impact, particularly in areas like diagnostics, personalized medicine, clinical workflow optimization, and data analytics platforms that empower healthcare providers and researchers. Dave's keen eye for product market fit and sustainable business models makes him a valuable partner for founders navigating the complex healthcare landscape.
Wigder's career background showcases a strong foundation in product management and technology development, often within high-growth environments. Prior to his tenure at PathAI, his experience likely spanned various roles where he honed his skills in product strategy, user experience, software development lifecycle management, and cross-functional team leadership. This rich history has equipped him with a comprehensive understanding of what it takes to build, launch, and scale successful technology products, especially in regulated and impactful sectors like healthcare. His expertise extends to understanding the nuances of bringing complex AI solutions from concept to commercialization, making him a sought-after advisor and investor.
While specific notable investments are often private or emerging, Dave Wigder's involvement typically centers around companies poised for significant disruption in health tech. He is known for backing founders with strong technical acumen and a clear vision for solving critical problems within healthcare through innovative product solutions. His investment philosophy emphasizes long-term growth and the potential for technology to fundamentally improve the efficiency and effectiveness of healthcare delivery worldwide. Dave Wigder continues to be a pivotal force, both in his leadership at PathAI and through his strategic investments, driving forward the future of healthcare technology.
